Authors' objectives: Psoriatic arthritis occurs when the joints are affected in people who already have psoriasis (a skin condition that causes itchy red, flaky, scaly patches of skin). People with psoriatic arthritis often feel pain and experience stiffness in joints, for example, in the hands, feet, knees, neck, spine and elbows. Abatacept is a new drug for the treatment of psoriatic arthritis which is injected under skin. Studies are currently underway to see how well the drug works and whether it is safe to use in patients with the condition. If abatacept is licensed for use in the UK, it could offer a new treatment option for patients with psoriatic arthritis to reduce disability when current treatments have not worked.

Project Status: Completed

Year Published: 2015

URL for published report: http://www.hsric.nihr.ac.uk/topics/abatacept-for-psoriatic-arthritis-second-line/

English language abstract: An English language summary is available

Publication Type: Not Assigned

Country: England, United Kingdom

Organisation Name: NIHR Horizon Scanning Centre

Contact Address: The NIHR Horizon Scanning Centre, Department of Public Health, Epidemiology, and Biostatistics, School of Health and Population Sciences, University of Birmingham, 90 Vincent Drive, Edgbaston, Birmingham, B15 2SP. United Kingdom. Tel: +44 121 414 7831, Fax: +44 121 2269

Contact Name: c.packer@bham.ac.uk

Contact Email: c.packer@bham.ac.uk

Copyright: NIHR Horizon Scanning Research&Intelligence Centre (NIHR HSRIC)